378
Views
4
CrossRef citations to date
0
Altmetric
Meeting Report

Gestational diabetes: screening for all, which test and which treatment?

&
Pages 165-167 | Published online: 10 Jan 2014

References

  • Gluckman PD, Hanson MA. Living with the past: evolution, development, and patterns of disease. Science305, 1733–1735 (2004).
  • Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world – a growing challenge. N. Engl. J. Med.356, 213–215 (2007).
  • Jiwani A, Marseille E, Lohse N, Damm P, Hod M, Kahn JG. Gestational diabetes mellitus: results from a survey of country prevalence and practices. J. Mat. Fet. Neon. Med. doi:10.3109/14767058.2011.587921 (2011) (Epub ahead of print).
  • HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR et al. Hyperglycemia and adverse pregnancy outcomes. N. Engl. J. Med.358, 1991–2002 (2008).
  • IADPSGCP. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diab. Care3, 676–682 (2010).
  • Pirkola J, Pouta A, Bloigu A et al. Risks of overweight and abdominal obesity at age 16 years associated with prenatal exposure to maternal prepregnancy overweight and gestational diabetes mellitus. Diab. Care33, 1115–1121 (2010).
  • Rian EA. Diagnosing gestational diabetes. Diabetologia54, 480–486 (2011).
  • Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N. Engl. J. Med.343, 1134–1138 (2000).
  • Rowan JA, Hague WM, Gao W, Battin MR, Moore MP. Metformin versus insulin for the treatment of gestational diabetes. N. Engl. J. Med.358, 2003–2015 (2008).
  • Moore LE, Clokey D, Rappaport VJ, Curet LB. Metformin compared with glyburide in gestational diabetes: a randomized controlled trial. Obstet. Gynecol.115, 55–59 (2010).
  • Cheng YW, Chung JH, Block-Kurbisch I, Inturrisi M, Caughey AB. Treatment of gestational diabetes mellitus: glyburide compared to subcutaneous insulin therapy and associated perinatal outcomes. J. Mat. Fet. Neon. Med. doi:10.3109/14767058.2011.580402 (2011) (Epub ahead of print).
  • Rowan JA, Rush EC, Obolonkin V, Battin M, Wouldes T, Hague WM. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age. Diab. Care34, 2279–2284 (2011).
  • Libby G, Donnelly LA, Donnan PT, Alessi DR, Morris AD, Evans JMM. New users of metformin are at low risk of incident cancer. Diab. Care32, 1620–1625 (2009).
  • Martin-Castillo B, Vazquez-Martin A, Oliveras-Ferraros C, Menendez JA. Metformin and cancer. Cell Cycle9, 1057–1064 (2010).
  • Tan BK, Adya R, Chen J, Lehnert H, Saint Cassia LJ, Randeva HS. Metformin treatment exerts antiinvasive and antimetastatic effects in human endometrial carcinoma cells. J. Clin. Endocrinol. Metab.96(3), 808–816, (2011).
  • Ersoy C, Kiyici S, Budak F et al. The effect of metformin treatment on VEGF and PAI-1 levels in obese Type-2 diabetic patients. Diab. Rev. Clin. Pract.81, 56–60 (2008).
  • Dowling RJO, Goodwin PJ, Stambolic V. Understanding the benefit of metformin use in cancer treatment. BMC Med.9, 33 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.